chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: randomly smelling cigarette smoke despite not being around it at all; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation . Medical history included COVID-19.Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination .Concomitant medications included sertraline hydrochloride (ZOLOFT) for an unknow indication from an unknown date. On 19Mar2021, the patient experienced randomly smelling cigarette smoke despite not being around it at all. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event smell alteration was not recovered at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 08:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: Random bruising has developed on arms, legs, hips; This is a spontaneous report received from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EK10158) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. The patient had penicillin allergy. The patient did not receive any medication within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. On 10Apr2021, the patient experienced random bruising which developed on arms, legs and hips. Therapeutic measures were not taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event random bruising which developed on arms, legs and hips were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Periorbital swelling
Clinical narrative: Swollen under eyes and pressure in eyes lids from swelling; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 07:45, the patient experienced swollen under eyes and pressure in eyes lids from swelling. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen under eyes and pressure in eyes lids from swelling was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Photopsia, Vision blurred
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included traumatic brain injury (reported as mtbi). The patient was allergic to animals. The patient previously had gluten and experienced gluten sensitivity (gluten allergy). The patient did not take any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced sporadic blurry vision for 4-5 days and was seeing stars when getting up 2-3 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events.  The clinical outcome of the events sporadic blurry vision for 4-5 days and seeing stars when getting up 2-3 days was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Lymphadenopathy
Clinical narrative: Swollen lymph nodes in neck; head feeling "foggy"; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 02Apr2021 at 16:00(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history was not included. The patient was allergic to fish and seafood. Concomitant medications included omeprazole magnesium (OMEPRAZOLE), vitamin c (MANUFACTURER UNKNOWN) 20Mg and multi-B Vitamin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:30 the patient experienced swollen lymph nodes in neck and head feeling "foggy" going on 2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. On 11Nov2020, the patient underwent nasal swab and the result was negative. The clinical outcome of the event swollen lymph nodes in neck and head feeling "foggy" were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Headache, Hyperhidrosis
Clinical narrative: Chills,; fever; sweating; headache; loss of appetite; joint pain; This is a spontaneous report from a contactable other healthcare professional, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 06Apr2021 at 15:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no allergies to food, medications or other products. The patient did not receive any other medications  within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. On 09Apr2021 at 03:00 the patient experienced chills, fever, sweating, headache, loss of appetite and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, fever, sweating, headache, loss of appetite & joint pain was recovered, on unknown date in Apr2021  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills,; fever; sweating; headache; loss of appetite; joint pain; This is a spontaneous report from a contactable other healthcare professional, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 06Apr2021 at 15:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no allergies to food, medications or other products. The patient did not receive any other medications  within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. On 09Apr2021 at 03:00 the patient experienced chills, fever, sweating, headache, loss of appetite and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, fever, sweating, headache, loss of appetite & joint pain was recovered, on unknown date in Apr2021  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; headache; This is a spontaneous report from a contactable consumer. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW00153) via an unspecified route of administration in the arm left on 13Apr2021 at 10:30 (at the age of 28-year-old) as a single dose. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unspecified date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. After the first dose of vaccination the patient had been tested for COVID-19.  On 07Apr2021, the patient underwent nasal swab test and the result was negative. On 14Apr2021 at 08:00 the patient experienced fever and headache. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever and headache was recovering at the time of this report.   No follow up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Feeling abnormal, Inappropriate schedule of product administration, Lymphadenopathy, Nausea
Clinical narrative: Brain fog; intense body pain; swollen lymph nodes; nausea; vomiting; fever; unintended weight loss; dehydration; Inappropriate schedule of vaccine administered.; This is a spontaneous report from a contactable healthcare professional, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 14:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and allergy to milk, gluten. Concomitant medications included montelukast sodium (MONTELUKAST), sertraline (MANUFACTURER UNKNOWN) and unspecified birth control (MANUFACTURER UNKNOWN); all from unknown start dates for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283,) via an unspecified route of administration in the left arm on 12Jan2021 at 17:00(at the age of 20-years-old) as a single dose COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On unknown date in Apr2021, the patient gave nasal swab for Sars-CoV-2 test and the result was negative. On 31Mar2021 at 14:00, the patient experienced brain fog, intense body pain, swollen lymph nodes, nausea, vomiting, fever, unintended weight loss and dehydration. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events brain fog, intense body pain, swollen lymph nodes, nausea, vomiting, fever, unintended weight loss and dehydration was ongoing at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vomiting, Weight decreased
Clinical narrative: Brain fog; intense body pain; swollen lymph nodes; nausea; vomiting; fever; unintended weight loss; dehydration; Inappropriate schedule of vaccine administered.; This is a spontaneous report from a contactable healthcare professional, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 14:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and allergy to milk, gluten. Concomitant medications included montelukast sodium (MONTELUKAST), sertraline (MANUFACTURER UNKNOWN) and unspecified birth control (MANUFACTURER UNKNOWN); all from unknown start dates for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283,) via an unspecified route of administration in the left arm on 12Jan2021 at 17:00(at the age of 20-years-old) as a single dose COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On unknown date in Apr2021, the patient gave nasal swab for Sars-CoV-2 test and the result was negative. On 31Mar2021 at 14:00, the patient experienced brain fog, intense body pain, swollen lymph nodes, nausea, vomiting, fever, unintended weight loss and dehydration. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events brain fog, intense body pain, swollen lymph nodes, nausea, vomiting, fever, unintended weight loss and dehydration was ongoing at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dry throat, Migraine, Paraesthesia oral
Clinical narrative: Tingliness on lips; Dry throat; Dizziness; Migraine; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0164) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to shellfish and lamb. The patient had known allergies to ibuprofen. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 14:30, within 5 minutes of vaccination, the patient experienced tingliness on her lips, dry throat, and dizziness. Dry throat continued for the remainder of the day. On 13Apr2021, the patient's migraine came the night of the vaccination and she had it even after 48 hours. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingliness on lips, dry throat, dizziness and migraine was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: 3.5" diameter swelling; Hot to the touch; Redness; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 12Apr2021 at 09:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and patient was healthy. The patient did not have any allergies to medications, food and other products. Concomitant medications included unspecified normally taken medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 12Apr2021 at 10:00, the patient experienced 3.5" diameter swelling with redness & hot to the touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if patient received any treatment for the reported adverse events. The clinical outcome of the event 3.5" diameter swelling, redness and hot to the touch was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Pain, Pyrexia
Clinical narrative: Chills; Moderate fever; Headache; Body(joint) pain; Body(joint) pain; This is a spontaneous report from a contactable consumer, the parent. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 at 15:15 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 15:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 06:00, the patient experienced chills, moderate fever, headache and body(joint) pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, moderate fever, headache and body(joint) pain was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: Fever of 101; Chills; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin. The patient did not receive any concomitant medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 12:00 the patient experienced Fever of 101.The patient did not receive any treatment for the event. On 14Apr2021 at 12:00 the patient experienced fever of 101(units unknown), chills and muscle pain. The clinical outcome of the events fever of 101, chills and muscle pain was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Retching, Vomiting
Clinical narrative: throwing up rapidly multiple times; dry heaving because my body kept wanting to throw up; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 12:15 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unknown birth control medication from an unknown date taken within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 at 09:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 02:00 the patient experienced throwing up rapidly multiple times until there was nothing left in stomach, then the patient was dry heaving because the body kept wanting to throw up. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events.  Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcomes of the events throwing up, dry heaving were recovered on 15Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling hot, Mass, Neck pain, Pain in extremity
Clinical narrative: Arm swelling; lump/ lump still moving/ lump then moved up my neck/ the lump moved up into my head; lump hot to touch; Arm lots of pain/ painful on full right side of arm; Shoulders painful; Lump then moved up my neck  painful; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El2614) via an unspecified route of administration in the right arm on 06Apr2021 at 16:30(at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 17:30, the patient experienced arm swelling and could not lift arm, no range of motion and had lump which was hot to touch. The lump moved up her arm, caused lots of pain and could not use arm. The lump moved across the shoulders which was painful. She could not lie on the right side and the lump was moving and hot to  touch. The lump then moved up to neck, hot to touch, painful on full right side of arm shoulder and neck .The lump then moved up into her head. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm swelling, lump, hot to touch, arm lots of pain, shoulders painful lump then moved up my neck hot to touch painful was recovered with sequalae on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Arm swelling; lump/ lump still moving/ lump then moved up my neck/ the lump moved up into my head; lump hot to touch; Arm lots of pain/ painful on full right side of arm; Shoulders painful; Lump then moved up my neck  painful; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El2614) via an unspecified route of administration in the right arm on 06Apr2021 at 16:30(at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 17:30, the patient experienced arm swelling and could not lift arm, no range of motion and had lump which was hot to touch. The lump moved up her arm, caused lots of pain and could not use arm. The lump moved across the shoulders which was painful. She could not lie on the right side and the lump was moving and hot to  touch. The lump then moved up to neck, hot to touch, painful on full right side of arm shoulder and neck .The lump then moved up into her head. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm swelling, lump, hot to touch, arm lots of pain, shoulders painful lump then moved up my neck hot to touch painful was recovered with sequalae on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Asthenia, Back pain, Chills
Clinical narrative: Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; aches and pains back and shoulder especially; aches and pains back and shoulder especially; Lack of energy; This is a spontaneous report from a contactable consumer. This 59-year-old male consumer (patient) reported that he received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6207) via an unspecified route of administration on 14Apr2021 at 11: 00AM (at 59-year-old) on left arm as dose 1, single for COVID-19 immunization. The medical history of the patient included Low thyroid or hypothyroid, Ragweed pollen and covid (prior to the vaccination). The patient did not receive any other vaccine in four weeks and received normal medications in two weeks. On 08Apr2021 the patient underwent nasal swab test for covid-19 and was tested negative. On an unknown date at about 01: 30 am, the patient had chills and jerky body movements which he took like an anxiety attack. He also had deep breathing sessions as it was hard to get enough air. He did calm himself down and got warm to help with the chills. He was up doing some cleanup work and would have been asleep at the time of the anxiety attack. This am after 8 hours of sleep with Tylenol pm I he felt warm and then chilly at times some aches and pains back and shoulder especially. He had lack of energy to get up and do things around the house but that may be the Tylenol pm groggy effect (1/2 pill diphenhydramine HCI 25mg or 12.5mg took plus tylenol250mg). The patient was recovering.  No follow up attempts were possible. No further information was expected.  Follow-Up (18Aug2021): Follow-up attempts were completed. No further information was expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dyskinesia, Dyspnoea, SARS-CoV-2 test
Clinical narrative: Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; Well at about 130 am I had chills and jerky body movements which I liken to an anxiety attack.  I also had deep breathing sessions like it was hard to get enough air. I did calm myself down and get wa; aches and pains back and shoulder especially; aches and pains back and shoulder especially; Lack of energy; This is a spontaneous report from a contactable consumer. This 59-year-old male consumer (patient) reported that he received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6207) via an unspecified route of administration on 14Apr2021 at 11: 00AM (at 59-year-old) on left arm as dose 1, single for COVID-19 immunization. The medical history of the patient included Low thyroid or hypothyroid, Ragweed pollen and covid (prior to the vaccination). The patient did not receive any other vaccine in four weeks and received normal medications in two weeks. On 08Apr2021 the patient underwent nasal swab test for covid-19 and was tested negative. On an unknown date at about 01: 30 am, the patient had chills and jerky body movements which he took like an anxiety attack. He also had deep breathing sessions as it was hard to get enough air. He did calm himself down and got warm to help with the chills. He was up doing some cleanup work and would have been asleep at the time of the anxiety attack. This am after 8 hours of sleep with Tylenol pm I he felt warm and then chilly at times some aches and pains back and shoulder especially. He had lack of energy to get up and do things around the house but that may be the Tylenol pm groggy effect (1/2 pill diphenhydramine HCI 25mg or 12.5mg took plus tylenol250mg). The patient was recovering.  No follow up attempts were possible. No further information was expected.  Follow-Up (18Aug2021): Follow-up attempts were completed. No further information was expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Feeling abnormal, Headache, Pyrexia
Clinical narrative: Cloudy head; Headache; Fever of 99.7; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8729) via an unspecified route of administration in the right arm on 13Apr2021 at 17:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, panic disorder and depression. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), levocetirizine (MANUFACTURER UNKNOWN), rabeprazole (MANUFACTURER UNKNOWN) and calcium lactate (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6207) via an unspecified route of administration in the right arm on 23Mar2021 at 14:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation and also received codeine (MANUFACTURER UNKNOWN) and azithromycin (ZPAKS) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021, the patient experienced persistent headache, fever of 99.7 and intense fatigue. On 15Apr2021, patient left with fatigue and cloudy head. On 14Apr2021, the patient body temperature was measured and the result was 99.7 (unspecified units). The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of headache, fever of 99.7, fatigue and cloudy head was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Rash
Clinical narrative: Rash on back, front; Hands body tingling; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 16:00(at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient was not allergic to medication, food and other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 15:00(at the age of 21-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) of dose 20 milligram once daily from an unknown date for an unknown indication. On 14Apr2021 at 16:00, the patient experienced rash on back, front and hands body tingling. No therapeutic measures were taken as a result of the events. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event rash on back, front and hands body tingling was not recovered at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Ear pain, Lymphadenopathy, Sensation of foreign body
Clinical narrative: 2 hours later developed tightness in my chest which caused to begin coughing; 2 hours later developed tightness in my chest which caused to begin coughing; developed a lump feeling in the left side of throat; developed a lump feeling in the left side of throat. As it progressed felt the gland in neck located near ear had swelled and was pushing and making the ear hurt.; developed a lump feeling in the left side of throat. As it progressed felt the gland in neck located near ear had swelled and was pushing and making the ear hurt.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 at 12:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, asthma, underactive thyroid, penicillin allergy and sulfonamide allergy. The patient received unspecified medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 12:35, 20 minutes after vaccination, the patient developed a lump feeling in the left side of her throat, as it progressed she felt the gland in her neck located near her ear had swelled and was pushing and making her ear hurt. On 15Apr2021 at 14:15, 2 hours later, the patient developed tightness in chest which caused her to begin coughing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported event and included treatment herself with Benadryl and albuterol inhaler. The clinical outcome of the events lump feeling in the left side of her throat, as it progressed she felt the gland in her neck located near her ear had swelled and was pushing and making her ear hurt and tightness in chest which caused her to begin coughing was resolved on 15Apr2021.  No follow-up attempts are needed. No further information is expected..
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Vomiting
Clinical narrative: Vomiting; Slight headaches; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0151) in the right arm on 14Apr2021 at 15:15 (at the age of 46-years-old) as a dose for COVID-19 immunisation. Medical history included COVID-19, asthmatic, high blood pressure, high cholesterol, post-traumatic stress disorder (PTSD), acid reflux, migraine and all year-round seasonal allergy. The patient received concomitant medication within two weeks of vaccination. The patient had allergies to tramadol, seafood, lisinopril and sulphur antibiotics. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 08:00, the patient experienced vomiting, slight headaches and dizziness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events vomiting, slight headaches and dizziness were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Eye disorder, Ocular discomfort, Swelling of eyelid
Clinical narrative: The whites of one eyeball swelled up, almost like a blister on the eyeball; Sensations of pressure buildup; Minor swelling of the eyelid; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 07Apr2021 at 15:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergy to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive other medications within 2 weeks of vaccination. The patient previously received a single dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) in the left arm on 17Mar2021 at 15:00 for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 23:00, the patient reported that the whites of one eyeball swelled up, almost like a blister on the eyeball and sensations of pressure build-up and minor swelling of the eyelid. The patient did not had possible allergic stimuli. Therapeutic measures were not taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events eye disorder, sensation of pressure in eye and swelling of eyelid were recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Headache
Clinical narrative: Vivid dreams; Mild headache; This is a spontaneous report from a contactable nurse, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 10:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021, the patient experienced vivid dreams and mild headache. The patient did not receive any treatment for the events. The clinical outcome of the events vivid dreams and mild headache were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: Fever 102*; Severe headache; Body aches; Chills; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 11:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Other medication received within two weeks of vaccination was not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 04:00, the patient experienced fever 102* (unspecified units), severe headache, body aches, chills, tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever 102* (unspecified units), severe headache, body aches, chills, tiredness was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 102*; Severe headache; Body aches; Chills; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 11:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Other medication received within two weeks of vaccination was not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 04:00, the patient experienced fever 102* (unspecified units), severe headache, body aches, chills, tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever 102* (unspecified units), severe headache, body aches, chills, tiredness was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.